Quest Diagnostics (DGX) Revenue — Quarter Ended Jun 30, 2025
Revenue increased in the quarter, driven by growth in the Diagnostic Information Services segment. The overall rise reflected continued strength in the core business.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q2
Revenue increased in the quarter, driven by growth in the Diagnostic Information Services segment. The overall rise reflected continued strength in the core business.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$2.8B
Revenue reported for this quarter.
Quarter-over-quarter
+4.1%
Change from the immediately preceding quarter.
Year-over-year
+15.2%
Change from the comparable year-ago quarter.
Trailing four quarters
$10.5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $2.5B | +8.4% |
| Dec 31, 2024 | $2.6B | +14.6% |
| Mar 31, 2025 | $2.7B | +12.1% |
| Jun 30, 2025 | $2.8B | +15.2% |
Revenue performance
The Diagnostic Information Services segment posted a higher net revenue, while the other segment saw a slight decline. Total net revenue advanced compared with the prior quarter and the same quarter last year.
Quarterly comparison
Compared with the immediately preceding quarter, revenue increased. Versus the same quarter one year earlier, revenue also showed a substantial increase.
What to watch
The decline in the other segment's revenue may warrant monitoring for any sustained weakness.